Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can earning points for shots boost community vaccination?

NCT ID NCT06890559

Prevention Sponsor: Bo Yan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This trial tests whether a digital platform that rewards people with points for getting vaccinated can increase uptake of vaccines not covered by China's national program, such as HPV, flu, and pneumonia vaccines. About 5,120 residents in certain districts will either receive the points-based incentive or standard activities. Points are earned per family member and can be redeemed for gifts or services. The goal is to see if this approach raises vaccination rates and encourages other preventive behaviors like cancer screenings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A digital platform with points-based financial incentives for completing vaccinations and preventive health behaviors
What this could lead to
If effective, this approach could offer a low-cost, scalable way to increase vaccination rates and preventive care in communities.
What could go wrong
The trial is early and relies on voluntary participation and digital platform use, which may limit its reach or effectiveness in some groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 5,120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Do not move from the original research and implementation site within the next year; * Voluntarily participate in the study and sign the informed consent; * No mental disorder or cognitive impairment, able to understand and cooperate with research requirements. Exclusion Criteria: * Have contraindications related to vaccination; * The state of the body during the intervention period is not suitable for vaccination.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vaccination uptake are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vaccination uptake

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Jiangshan City Disease Prevention and Control Center

    RECRUITING

    Quzhou, Zhejiang, 324000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.